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Following the rapid acceptance of laparoscopic cholecystectomy,
a few adventurous surgeons ‘dared to boldly go where no one had
gone before. “They sought to achieve the same reduction in morbid
ity while accomplishing the same surgical goals. This paper will
briefly review the current status of minimal access surgery for the
solid organs of the abdomen. It will focus on the indications, risks,
limitations, and on the balance between the trauma of access and
the trauma of the procedure itself As new techniques and equip
ment emerge and experience and data are accumulated, this
balance may shift. Some of these procedures are in their infancy
while others are rapidly becoming the new “Gold Standard”.
Introduction
In March of this year laparoscopic cholecystectomy celebrated its
eleventh birthday. Who in 1987 would even have thought of it? Open
cholecystectomy was a well-established procedure which any com
petent surgeon could perform with a minimum of morbidity. Even
Mouret, who was aware of the latest laparoscopic techniques,
thought little of it.’ One day, as he finished a gynecological proce
dure on a patient who also had symptomatic cholelithiasis, he shifted
his laparoscope to the subhepatic area and found a fairly free and
supple gallbladder. When he decided to perform the operation
laparoscopically rather than opening her upper abdomen, he fired
the first salvo in a surgical revolution which continues to this day.
Mouret was not particularly impressed and did not report the
operation. However, other surgeons in France, the US, and else
where adopted and polished the technique. As a result, laparoscopic
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After the success of this initial procedure, creative surgeons have
turned their attention to adapting laparoscopic or minimal access
techniques to other surgically treatable conditions. The attempts to
assess or to remove all or portions of the solid organs of the abdomen
have been among the most innovative and challenging of them all.
In deciding whether a minimal access technique has merit, we must
consider the balance between the trauma of the access and the
trauma of the procedure. Laparoscopic cholecystectomy has been so
successful because the major trauma of the procedure - the subcostal
incision - has been replaced by 3-4 small access ports. For other
procedures: appendectomy, inguinal hernia repair, etc. hospital
stays are short and differences in access trauma are harder to prove.
As a result, the acceptance of these procedures has been more
gradual.
This paper will briefly review the current status ofminimal access
surgery for the solid organs of the abdomen. It will focus on the
indications, risks, limitations, and on the balance between the
trauma of access and the trauma of the procedure itself. As new
techniques and equipment emerge and experience and data are
accumulated, this balance may shift. Some of these procedures are
in their infancy while others are rapidly becoming the new “Gold
Standard”.
The Adrenal
Adrenalectomy is a relatively recent addition to the catalogue of
laparoscopic or minimal access techniques. In their retroperitoneal
location along the medial aspect of each kidney, the adrenal glands
are ideally suited to such an approach. Laparoscopy may improve
exposure, hemostasis and specimen retrieval while reducing the
morbidity of the access considerably. Careful localization and
characterization is necessary to assure safe and complete removal of
adrenal lesions.
Indications for Laparoscopic Adrenalectomy
Adrenal Cortical Adenomas
Cushing ‘s Syndrome
The most common cause of Cushing’s syndrome is the pituitary
hypersecretion of adrenocorticotropic hormone (ACTH). This ac
counts for 60-70% of cases. Primary adrenal tumors which produce
excessive glucocorticoids account for 15-20% of patients with the
syndrome. The remainder have ectopic ACTH-secreting tumors.
Patients with elevated cortisol levels and low plasma ACTH should
undergo a CT or MRI to search for a primary adrenal lesion. One of
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our patients was a young woman with the typical features of
Cushing’s syndrome who presented with an acute psychotic break
due to the excess production of cortisol. After the laparoscopic
removal of a unilateral adenoma, her “psychosis” abated and the
Cushingoid stigmata are gradually resolving. Unilateral laparoscopic
adrenalectomy is appropriate for discrete masses. Bilateral adrena
lectomy is an option for those with bilateral adrenal hyperplasia who
have failed to respond to treatment of a primary pituitary cause.
Aldosteronoma
Conn’s syndrome is the result of an excess production of aldoster
one by cells of the adrenal glomerulosa. Refractory hypertension
and spontaneous hypokalemia should prompt the search for a tumor.
Sixty-five percent of primary hyperaldosteronism is due to an
adenoma. Bilateral adrenal hyperplasia accounts for most of the
remaining cases. Once the diagnosis of primary aldosteronism is
made the distinction between adenoma and hyperplasia must be
made to assure the proper treatment. The most useful tests to make
this distinction are CT, MRI, and adrenal venous sampling of
aldosterone levels. The small size (1-3cm) of benign aldosterone
producing adenomas make them ideal for laparoscopic removal.
Adrenal Medullary Tumors
Pheochromocytoma
These lesions are catecholamine-secreting tumors that arise within
the chromaffin tissue of the sympathetic nervous system. They are
very uncommon and account for only 0.1% ofpatients with diastolic
hypertension.2They appear far more often on examinations than in
the Clinic. Although the majority of these tumors occur within a
single adrenal gland, they may be bilateral in 10%, may occur in
ectopic sites in 10-15%, and may be malignant in 10%. Conse
quently, the precise characterization and localization of a suspected
pheochromocytoma must precede any attempt to remove it.
The classic patient presents with recurrent paroxysmal hyperten
sion, headaches, palpitations, anxiety, and sweating. Increased
urinary catecholamines and their metabolites (VMA and
metenephrines) establish the diagnosis. Localization with CT, MRI,
or131-metaiodolbenzyl-guanidine(31I-MffiG) scanning is essen
tial for preoperative planning. During a MRI, T2 weighted images
of pheochromocytomas are very bright while those of adrenal
cortical adenomas have a lower signal density.3Since‘311-MIBG is
taken up by pheochromocytomas, but not by normal adrenal medul
lary tissue, this scan complements the MRI in excluding extra-
adrenal or malignant lesions.4
There is at least one family in Hawaii with the genetic mutation
associated with the Multiple Endocrine Neoplasia syndrome (MEN
ll.). Family members with this mutation are being screened for
pheochromocytoma prior to undergoing a prophylactic thyroidec
tomy to avoid developing a medullary carcinoma. We have recently
performed bilateral laparoscopic adrenalectomies for one member
of this family who was found to have 8cm pheochromocytomas. She
did well and is now recovering from her radical thyroidectomy for
her medullary carcinoma.
Other Adrenal Tumors
Masses discovered incidentally on CT scan should be evaluated
for the excess production of cortisol, aldosterone, and catechola
mines, If these tests are negative and the lesions are <3 cm, they may
be followed with serial CT scans. Because of the higher risk of
carcinoma, lesions >6 cm should be removed irrespective of their
functional status. The availability of laparoscopic adrenalectomy
may make this the preferred treatment for incidentally discovered
tumors which are 3-6 cm in size.
Laparoscopic Adrenalectomy
The first laparoscopic adrenalectomies were performed through
an anterior transabdominal approach.5This proved to be tedious and
the exposure is significantly improved by placing the patient in a
lateral decubitus position.6 In this position, gravity increases the
exposure as the viscera fall away from the operative field. Posterior
and retroperitoneal laparoscopic approaches have their advocates.6
81t is clear that the procedure should be tailored to the number, size,
and location of the tumor(s) as well as to the surgeon’s preference
and experience.
Results of laparoscopic adrenalectomy
The early learning curve associated with any new procedure will
result in longer operative times and higher costs. With experience,
laparoscopic adrenalectomy can be performed with operative times
comparable to more traditional methods. Hospital stay, narcotic
requirements, and recovery are all improved when minimal access
techniques are used.89 Further follow-up will be required to be sure
that the recurrence rate and the incidence of missed lesions, both
ectopic and bilateral, is equivalent to open methods. Improved
imaging techniques should make this a very rare occurrence.
Prinz RA7reported an early comparison of laparoscopic adrena
lectomy to two open approaches. His results are summarized in
Table 1.
Michel Gagner, who was one of the first to perform a laparoscopic
adrenalectomy, recently reviewed his first 100 cases from the
Cleveland Clinic.8These results are shown in Table 2. Table 3
Summarizes our experience with open and laparoscopic adrenalec
tomy.
Conclusions
Laparoscopic adrenalectomy is a relatively new procedure. Its
safety and efficacy in experienced hands has been clearly demon
strated in a growing number of reports. By reducing the trauma of
access, it has definite advantages over the traditional open methods.
However, open adrenalectomy is still the preferred method for
patients with adrenal cortical malignancies.
The Kidney
The first successful human nephrectomy was performed in 1869
by Gustav Simon.9Although it has become a standard operation for
urologists, the large incision required is associated with significant
pain, prolonged recovery, and the risks of infection and herniation.
The successful application of minimal access techniques to nephre
ctomy would reduce the trauma of access and hasten recovery. After
working out their technique in the animal lab, Drs Clayman and
Kavoussi performed the first laparoscopic nephrectomy in June of
1990.10
Indications for Laparoscopic Nephrectomy
Benign renal diseases requiring nephrectomy are suitable to the
laparoscopic approach. These include end-stage reflux nephropa
HAWAH MEDICAL JOURNAL, VOL 57, NOVEMBER 1998
711
thy; renal vascular hypertension; poorly functioning kidney due to
chronic obstruction; recurrent pyelonephritis; and, with extensive
experience, living-related donor nephrectomy. Laparoscopic total
or radical nephrectomy has also been reported for small (< 5cm)
renal tumors.
Operative Approaches
Both the lateral, transabdominal” and the retroperitoneal’2ap
proaches have been described. The latter is facilitated by the use of
dissection balloons first described by Gaur.’3 These balloons are
now commercially available and are similar to the ones used for
laparoscopic inguinal hernia repair. This is particularly valuable for
patients who have had prior abdominal operations. The choice of
approach will also be governed by the surgeon’s experience and
preferences.
Results of Laparoscopic Nephrectomy
Clayman, et al have one of the largest series of laparoscopic
nephrectomies. A recent report’4 of their initial experience is pre
sented in Table 4. Table 5 summarizes several authors’ results with
laparoscopic retroperitoneal nephrectomy.
Two patients have undergone laparoscopic nephrectomy for be
nign disease at the Kaiser Foundation Hospital in Honolulu. Learn
ing from these early pioneers and from our own experience in other
complex laparoscopic procedures, we have had very similar results.
Laparoscopic Donor Nephrectomy
Donor nephrectomy is a unique operation. It confers absolutely no
benefit to the patient and damage to the removed kidney harms two
patients. Open donor nephrectomy is not without risk. Clayman cites
several series where the complication rate was similar to those
reported in his series listed above. However, Flowers’5(Table 6) has
reported excellent results in a case-controlled series which is now
>150 patient donors. He has proposed that if the procedure were
more available, more relatives might chose to become donors.
Conclusion
For properly selected patients, laparoscopic nephrectomy offers
the benefits of minimal access surgery while accomplishing the
same surgical goals. Those considering this approach should col
laborate with experienced laparoscopic colleagues to shorten the
“learning curve”. Whether laparoscopic donor nephrectomy will
find broader acceptance and increase the donor pool will require
careful monitoring of results from the pioneer centers.
The Spleen
The first successful splenectomy was performed during an explor
atory operation for a suspected ovarian tumor. The surgeon, Jules
Pean (1830- 1898), was a well respected pioneer in French surgery.
He was, perhaps, the first of the French surgeons whose efforts were
pivotal in the development of minimal access surgery. His skill in
removing a very large splenic cyst and the remaining spleen is
evident in his report. ‘ The operation took two hours and “less than
100 gms of blood were lost”. This was well before the availability
of electrosurgical, argon beam, ultrasonic, or surgical stapling
devices. The patient seemed to have had more trouble from the
chloroform-induced vomiting than from the operation!
I
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OperatingTime(min) 212 139 174
Blood Loss ml) 228 288 391
Length of Stay (days) 2.1 5.5 6.4
ParenteralAnalgesia(doses) 1.4 14.5 15.8
Table 2.—One hundred laparoscopic adrenalectomies at the Cleve
land Clinic. Gagner, 997&
Operating Time (mm) 123 (80 .360)
Size (cm) 4.95 (0.7- 12)
Blood Loss (ml) 70 (<20- 1300)
Conversion to open 3%
Complications 12%
Length of Stay (days) 2.4 (1 -19)
Parenteral Analgesia (doses) 5.5
Table 3.—Recent experience with laparoscopic and open adrenalec
tomy at Kaiser, Hawaii
Open Laparoscopic
(n=6) (n=9)
Mean Operating Time (mm) 170 165
Blood Loss (m 225 <50
Size(cm) 1-10 1.5-4
Length of Stay (days) 5.8 2
Parenteral Analgesia (doses) 16 6
Retum to Work (days) 25 7
Table 4.— Laparoscopic nephrectomy for benign and malignant









Blood Loss (ml) 211
Length of Stay (days) 31
Complications 37%
712
Indications for Laparoscopic Splenectomy
Splenectomy is often indicated for hematological diseases which
result in the damage or destruction of the formed elements of the
blood or for staging hematological malignancies. These include
immune’7’ and thrombocytopenic purpura, hemolytic
anemia,2°or Hodgkin’s lymphoma.2 Early in one’s experience,
small spleens in patients without significant co-morbidities are the
most appropriate. However, more experienced laparoscopists are
reporting the removal of very large specimens - in excess of 300
grams. Preoperative angiographic embolization of the splenic artery
may be helpful with these large spleens or early in a surgeon’s
experience. It is not usually necessary with the smaller ones and may
cause pancreatitis, especially if gel foam is used for the emboliza
tion)9We have not used preoperative embolization for our
laparoscopic splenectomies.
Searching for accessory spleens is an important step in the
procedure. Advanced laparoscopic skills and repositioning the
patient frequently to improve exposure are essential. Although there
is not general agreement on whether preoperative scanning is
necessary to identify accessory splenic tissue, it may be valuable in
obese patients or early on the a surgeon’s “learning curve”.
Most resected spleens are placed into a sturdy sac and morcellized
for removal. While this has raised questions about the suitability of
the specimen for pathological examination, the large pieces are
adequate in most cases.
Results of Laparoscopic Splenectomy
Until randomized, prospective trials are available, case-con
trolled studies are helpful in evaluating the procedure. One such trial
was recently published by Diaz.22 (Table 7)
Conclusions
As with the previously described procedures for adrenalectomy
and nephrectomy, laparoscopic splenectomy may permit us to
reduce the trauma of access while accomplishing the same surgical
goals. This is another “ideal operation” for laparoscopy and is well
on the way to establishing itself as the “gold standard” for the
procedure.8
The Pancreas
Pancreatic resections are usually performed for cancer, for the
intractable pain of chronic pancreatitis or for the drainage or resec
tion of pseudocysts.23For peripancreatic cancer, pancreati
coduodenectomy with adequate node clearance has shown steadily
improving results. With thorough staging,24 patients can be more
accurately chosen for exploration and attempted resection.
Laparoscopic surgery of the pancreas is still in its early stages of
development. Although the entire gland can be visualized
laparoscopically, it cannot be thoroughly palpated. Laparoscopic
ultrasound may allow us to overcome this obstacle.
Laparoscopic pancreaticoduodenectomy has been successfully
accomplished by a few exceptionally skilled surgeons.25’6However,
even they feel that the procedure is of little real benefit to the patient.
Currently, laparoscopic pancreatic surgery is best suited for the
localization and enucleation of benign islet cell tumors and distal
resections for chronic pancreatitis. Staging malignant tumors
laparoscopically and bypassing those which are unresectable are
also becoming more widely done.
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Table 5.— Laparoscopic retroperitoneal nephrectomy in several cen
ters. Perle, 199612
# Success OR EBL LOS Comps
(%) lime (ml) (d) (%)
(hrs)
154 63-100 1.9-5.1 <150 <3-8 0-15




Operating lime (mm) 212.8 226.3 0.1658
Conversion to Open - 6%
Blood Loss (ml) 408 122.3 0.0001
Length of Stay (days) 4.5 2.2 0.0001
Graft Survival (%) 64(98) 67 (97) 0.6191
[mean FU: 7 monthsj
Delayed Graft Function (%) 1 (2) 2 (3) 0.4961
Parenteral Analgesia (doses) 60.1 28.6 0.0001
Recovery (d)
Housework 26.9 8.8 0.0001
DrMng 31.6 11.1 0.0001
Wortdng 51.5 15.9 0.0001
Table 7.—Case-controlled study of open and laparoscopic sple
nectomy. Diaz, 1 997fl
Open Lap
Number 15 15
Splenic 492 305 N.S.
Weight (9) (64- 1130) (63 -878)
Operatinglime(min) 116±64 196±71 0.0031
Conversion to Open - 0
Blood Loss (ml) 359 ± 318 385 ± 168 N.S.
Length of Stay (days) 8.8 2.3 0.001
Return to Full Activity (days) 23 12 0.01
(14.46) (5-22)
Cost($)
OR 4372 12827 0.0001
Hospital 0.0005
Total Cost 10925 14216 N.S.





The size and complexity of the liver make it a formidable surgical
challenge. It remains the last of the abdominal organs to be ap
proached laparoscopically. From the method of exposure to the
removal of the specimen, evolving technology will be required to
make laparoscopic hepatic surgery safer and more effective.
Indications for Laparoscopic Hepatic Surgery
Diagnostic laparoscopy with intraoperative ultrasound can detect
primary and metastatic lesions which may have eluded prior studies.
The management of hepatic cysts has been changed by the advent of
laparoscopy. Unroofing and fenestration can lead to the resolution
of such cysts.27’8The reduced trauma of access can allow a much
more rapid recovery and occasionally spare the patient an unneces
sary celiotomy.24
The Future of Laparoscopic Hepatic Surgery
A small lesion metastatic to the left lobe may be considered for
laparoscopic resection. Using blunt and ultrasonic dissection such a
lesion can be resected with an adequate (2cm) margin of normal
tissue. When a major hepatic vein is encountered, switching to
mechanical lifters and a “gasless” laparoscopic environment may
help to prevent a CO2 embolism. Adventuresome surgeons in
Europe have attempted larger resections on both sides of the falci
form ligament.29However, better instruments for dissection and
hemostasis as well as the FDA’s approval of fibrin glue will be
necessary if such procedures are to become more commonly per
formed in the US.
Comment
Laparoscopic surgery has grown considerably from the early
“observation” and simple diagnostic efforts ofphysicians seeking to
avoid a surgical procedure for their patients. Surgeons skilled in the
techniques of minimal access surgery are now able to approach
nearly every organ of the body. While some of these procedures
remain developmental and controversial, others have become the
new “Gold Standard”. Since many of the problems reviewed are
relatively rare and the techniques can be difficult to learn, it may be
appropriate to concentrate the experience in a few very experienced
laparoscopists. This has been the approach at UCSF, Kaiser in
Hawaii, and at other institutions. The challenge for surgeons as we
wage an unwinable battle against obsolescence is to carefully
evaluate each new innovation and be certain that fundamental
surgical principles are honored and treatment goals are realistic. As
Lord Moran, Churchill’s personal physician, observed:
“The feasibility of an operation is not the best indication for its
performance.”
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